E-Cadherin Antagonizes Transforming Growth Factor β1 Gene Induction in Hepatic Stellate Cells by Inhibiting RhoA–Dependent Smad3 Phosphorylation
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Cadherins mediate cell-cell adhesion and catenin (ctn)-related signaling pathways. Liver fi-brosis is accompanied by the loss of E-cadherin (ECAD), which promotes the process of epithelial-mesenchymal transition. Currently, no information is available about the inhibi-tory role of ECAD in hepatic stellate cell activation. Because of ECAD’s potential for in-hibiting the induction of transforming growth factor b 1 (TGF b 1), we investigated whether ECAD overexpression prevents TGFb1 gene induction; we also examined what the molecular basis could be. Forced expression of ECAD decreased a -smooth muscle actin and vimentin levels and caused decreases in the constitutive and inducible expression of the TGFb1 gene and its downstream genes. ECAD overexpression decreased Smad3 phos-phorylation, weakly decreased Smad2 phosphorylation, and thus inhibited Smad reporter activity induced by either treatment with TGF b 1 or Smad3 overexpression. Overexpression of a dominant negative mutant of ras homolog gene family A (RhoA) diminished the abil-ity of TGF b 1 to elicit its own gene induction. Consistently, transfection with a constitu-tively active mutant of RhoA reversed the inhibition of TGF b 1-inducible or Smad3-inducible reporter activity by ECAD. Studies using the mutant constructs of ECAD revealed that the p120-ctn binding domain of ECAD was responsible for TGF b 1 repres-sion. Consistently, ECAD was capable of binding p120-ctn, which recruited RhoA; this prevented TGF b 1 from increasing RhoA-mediated Smad3 phosphorylation. In the liver samples of patients with mild or severe fibrosis, ECAD expression reciprocally correlated with the severity of fibrosis. Conclusion: Our results demonstrate that ECAD inhibits Smad3/2 phosphorylation by recruiting RhoA to p120-ctn at the p120-ctn binding domain, whereas the loss of ECAD due to cadherin switching promotes the up-regulation of TGF b 1 and its target genes, and facilitates liver fibrosis. (HEPATOLOGY 2010;52:2053-2064)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
Qian, X., Karpova, T., Sheppard, A. M., McNally, J., & Lowy, D. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600136 · Cited by 396
Choi, S. S., Omenetti, A., Witek, R. P., Moylan, C. A., Syn, W.-K., Jung, Y., Yang, L., Sudan, D. L., Sicklick, J. K., Michelotti, G. A., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00292.2009 · Cited by 219 · cited 5×
“As HSCs activate, the level of ECAD expression decreases.(7) Activated HSCs then promote the synthesis”
BackgroundInfluential
Cited by
Charbonney, E., Speight, P., Masszi, A., Nakano, H., & Kapus, A. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-04-0335 · Cited by 84
“This could be due to the fact that E-cadherin counteracts TGFβ-induced Rho activation (Cho et al., 2010).”
BackgroundMartin-Mateos, R., De Assuncao, T. M., Arab, J. P., Jalan-Sakrikar, N., Yaqoob, U., Greuter, T., Verma, V. K., Mathison, A. J., Cao, S., Lomberk, G., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.09.005 · Cited by 73
Kao, Y.-H., Lin, Y.-C., Lee, P.-H., Lin, C.-W., Chen, P.-H., Tai, T.-S., Chang, Y.-C., Chou, M.-H., Chang, C.-Y., & Sun, C.-K. (2020) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-020-00274-4 · Cited by 17
Metadata
- Authors
- Cho, I. J., Kim, Y. W., Han, C. Y., Kim, E. H., Anderson, R. A., Lee, Y. S., Lee, C. H., Hwang, S. J., & Kim, S. G.
- Venue
- Hepatology
- Published
- 2010-12
- Volume
- 52
- Issue
- 6
- Pages
- 2053-2064
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1983072760
- Cited by
- 72
- References
- 3
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.